Heart Failure: Device Management

Front Cover
Arthur Feldman
Wiley, Oct 29, 2009 - Medical - 200 pages
When you're considering device therapy for a patient with heart failure, be sure to consult this concise reference for the latest information on who benefits most from which device.In clear, straightforward prose, Dr. Feldman addresses: Resynchronization Therapy, ICD, Ultrafiltration, Impulse Therapy, Chronic Implantable Monitoring, Bioimpedance, EECP, and more. With chapters devoted to monitoring the patient on device therapy and the future of device therapy in heart failure, this book makes an important contribution to patient care.

What people are saying - Write a review

User Review - Flag as inappropriate

Many thanks Arthur
Your book has been written very simple but strong!
Good luck

Other editions - View all

About the author (2009)

Arthur M Feldman MD PhD
After receiving his B.A. degree from Gettysburg College, and M.S. and Ph.D. degrees from the University of Maryland, Dr. Feldman served as a post-doctoral fellow in physiology at the Johns Hopkins University School of Medicine. After completing his medical degree at the Louisiana State University School of Medicine, he returned to Johns Hopkins where he served as an intern, resident and cardiology fellow.
After joining the faculty in 1985, he was named the Director of the Belfer Laboratory for Molecular Biology of Heart Failure and the Director of the Heart Failure Research Program at The Johns Hopkins University School of Medicine. In 2004 Dr. Feldman joined the faculty at the University of Pittsburgh School of Medicine as the Harry S. Tack Professor of Medicine, Chief of the Division of Cardiology, and Director of the Cardiovascular Institute of the UPMC Health System.
In 2002, Dr. Feldman was named the Magee Professor of Medicine and Chairman of the Department of Medicine at Jefferson Medical College. He is a past President of the Heart Failure Society of America and of the Association of Professors of Cardiology. He has served on the editorial boards of many scientific journals and was elected to membership in organizations including Alpha Omega Alpha, the Association of University Cardiologists, the American Society for Clinical Investigation and the Association of American Physicians.
He has published over 200 peer-reviewed articles. Dr. Feldman's research has focused on molecular and clinical aspects of heart failure. Most recently he has chaired the Steering Committees for the PEECH, EMOTE and WEAR-IT trials and co-chaired the COMPANION study.

Bibliographic information